Xeris Biopharma will hold a webinar about its XP-8121 program on September 9, 2026.

Sep 9, 2026, 8:39 AM ETPaperworkRead the original at sec.gov

Neutral

Xeris announced a webinar and furnished slides and a press release on Sep 9. The filing includes no new clinical results or financial figures, so it does not change the company's outlook.

XERS · Xeris Biopharma Holdings, Inc.

AI read · Neutral

The AI's read

Xeris filed an 8-K saying it will host an XP-8121 program webinar and furnished slides and a press release. The filing gives no new clinical results or financial figures, so it does not change the company's outlook.

Get alerts for XERS

Follow Xeris Biopharma Holdings, Inc. (XERS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for XERS

Free on the App Store and Google Play, or on the web.